Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
PO 800394
UVA Health System
Charlottesville, VA 22908Phone+1 434-243-2884
Summary
- Dr. Xuemei Huang is a neurologist and clinician-scientist in Charlottesville, VA. She received her medical degree from Beijing Medical University and has been in practice 30 years. She specializes in movement disorder, neurodegenerative, and clinical pharmacology and is experienced in movement disorders and Parkinson's disease and related disorders. She has more than 200 publications and google H-index >65.
Education & Training
- University of North Carolina HospitalsResidency, Neurology, 1998 - 2000
- University of WashingtonResidency, Internal Medicine, 1997 - 1997
- Beijing Medical UniversityClass of 1987
Certifications & Licensure
- ID State Medical License 1996 - Present
- VA State Medical License 2024 - 2026
- NC State Medical License 1997 - 2024
- PA State Medical License 2008 - 2024
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI) Start of enrollment: 2012 Dec 01
- PF 06412562 in Subjects With Advanced Stage Parkinson's Disease Start of enrollment: 2018 Sep 24
Publications & Presentations
PubMed
- 81 citationsMulti-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline.Jiahui Wang, Clement Vachet, Ashley Rumple, Sylvain Gouttard, Clementine Ouziel
Frontiers in Neuroinformatics. 2014-02-06 - 1466 citationsGenome-wide association study reveals genetic risk underlying Parkinson's diseaseJavier Simón-Sánchez, Claudia Schulte, Jose Bras, Manu Sharma, J. Raphael Gibbs
Nature Genetics. 2009-12-01 - 63 citationsA single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophreniaMark S. George, Christine Molnar, Emily L. Grenesko, Berry Anderson, Qiwen Mu
Schizophrenia Research. 2007-07-01
Journal Articles
- Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient CareGary M Brittenham, Apostolos John Tsiouris, Lawrence Tanenbaum, Ajay Gupta, Martin R Prince, Jonathan W Weinsaft, Susan A Gauthier, Brian H Kopell, Michael G Kaplitt, ..., Journal of Magnetic Resonance Imaging
Authored Content
- Magnetic Resonance T1w/T2w Ratio: A Parsimonious Marker for Parkinson's DiseaseNovember 2018
- Systemic Effects of Deep Brain Stimulation on Synergic Control in Parkinson’s DiseaseFebruary 2018
Press Mentions
- Genetic Study Provides First-Ever Insight into Biological Origin of SchizophreniaJune 25th, 2020
- Use of a Graphic Memoir to Enhance Clinicians’ Understanding of and Empathy for Patients with Parkinson DiseaseMay 22nd, 2020
- Risk of Parkinson's Disease Increases with Statin or 'Cholesterol-Lowering' Drug UseAugust 21st, 2018
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: